Sign in

CIK 0001953926 · <br>Emerging growth company

Zenas BioPharma, Inc.

Sign in to watch
Ticker
ZBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-271-2954
Business address
852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
Former names
Zenas BioPharma (Cayman) Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-09-16 Fairmount Funds Management LLC Director Conversion +301,077 1,304,891
2024-09-16 Fairmount Funds Management LLC Director Purchase +300,000 $17.00 $5.1M 1,604,891
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series Seed Convertible Preferred Stock −357,143 0
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series A Convertible Preferred Stock −2,195,871 0
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series B Convertible Preferred Stock −6,163,236 0
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series C Convertible Preferred Stock −2,614,287 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +164,523 164,523
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +108,381 108,381
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +372,017 536,540
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion +48,254 156,635
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series Seed Convertible Preferred Stock −1,428,571 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series A Convertible Preferred Stock −941,088 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series B Convertible Preferred Stock −3,230,268 0
2024-09-16 MOULDER LEON O JR Chief Executive Officer Conversion · Series B Convertible Preferred Stock −418,996 0
2024-09-16 Nunn Jason Raleigh Director Conversion +1,505,388 1,505,388
2024-09-16 Nunn Jason Raleigh Director Purchase +441,176 $17.00 $7.5M 1,946,564
2024-09-16 Nunn Jason Raleigh Director Conversion +669,061 669,061
2024-09-16 Nunn Jason Raleigh Director Purchase +441,176 $17.00 $7.5M 1,110,237
2024-09-16 Nunn Jason Raleigh Director Conversion · Series C Convertible Preferred Stock −13,071,439 0
2024-09-16 Nunn Jason Raleigh Director Conversion · Series C Convertible Preferred Stock −5,809,528 0

Page 6 of 8 · 145 trades